Rchr
J-GLOBAL ID:201801012780020926
Update date: Mar. 16, 2025 Nabekura Tsukasa
ナベクラ ツカサ | Nabekura Tsukasa
- ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
- NKp46-CreERT2 transgenic mice
- 活性調節剤、これを含有する医薬品、および抗CD300a抗体
- ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
- Use of Celiac disease-associated CD300a gene-deficient mouse, activity modulator for CD300a-expressing cells, and medical and pharmaceutical agent comprising activity modulators for CD300a-expressing cells
- A Method for Generation of Antibodies Using Genetically Modified Dendritic Cells by Vectors
- Adoptive Gene and Cell Therapy with Immune Cells Genetically Modified by Retroviral Vectors
Return to Previous Page